Kezar Life Sciences Inc - COMMON-STOCK (KZR)

Historical Holders from Q2 2018 to Q1 2025

Symbol: KZR on Nasdaq
Type / Class: Equity / COMMON-STOCK
Shares outstanding: 7,227,333
All holders as of 31 Mar 2025: Q1 2025
Total 13F shares, excl. options: 0
Holdings value: $0
Number of holders: 0
Number of sells: -1
Average sells %: 0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Kezar Life Sciences Inc - COMMON-STOCK (KZR)

Filer	Ownership	Holdings Value	Nb Shares	Reporting Name	Report Period
Equal Talent Investments Ltd	8.66%	$474,645	616,502	Equal Talent Investments Limited	28 Feb 2025
Avidity Partners Management LP	6.9%	$386,952	502,600	Avidity Partners Management LP	31 Dec 2024
BML Investment Partners, L.P.	5.1%	$283,781	368,594	BML Investment Partners, L.P.	28 Feb 2025

Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q1	0	$0	-$2,838				0
2024 Q4	3,686	$2,838	-$28,944,788	$0	$0	$0.7699	1
2024 Q3	37,449,865	$28,947,595	+$901,306	$464	$10,670	$0.7732	54
2024 Q2	39,364,790	$23,615,521	-$4,000,586	$420	$1,920	$0.6	76
2024 Q1	44,720,598	$40,306,950	-$4,235,134	$541	$2,344	$0.9016	80
2023 Q4	49,383,993	$46,781,512	-$6,133,801	$758	$169,979	$0.9474	81
2023 Q3	55,483,503	$66,015,101	-$2,947,809	$683,705	$853,349	$1.19	81
2023 Q2	56,822,940	$139,215,632	-$10,696,319	$1,408,260	$1,761,550	$2.45	101
2023 Q1	60,055,283	$187,971,528	-$2,108,993	$1,771,893	$2,250,157	$3.13	134
2022 Q4	57,277,255	$403,229,451	-$11,090,479	$6,336	$1,292,544	$7.04	120
2022 Q3	56,469,842	$486,201,785	+$23,648,488	$191,000	$4,327,000	$8.61	126
2022 Q2	53,606,671	$443,221,355	+$61,093,967	$3,326,000	$27,920,000	$8.27	120
2022 Q1	44,087,335	$732,422,704	+$63,060,825	$2,481,000	$10,949,000	$16.62	119
2021 Q4	39,952,993	$668,007,601	+$202,581,406	$1,313,000	$4,455,000	$16.72	101
2021 Q3	28,072,332	$242,731,438	+$10,955,423		$980,000	$8.64	75
2021 Q2	27,643,956	$150,102,213	+$4,147,681	$0		$5.43	73
2021 Q1	26,599,958	$157,980,005	+$18,318,381	$71,000		$5.96	81
2020 Q4	23,537,490	$122,866,361	+$2,010,166	$69,000	$0	$5.22	75
2020 Q3	23,177,080	$112,175,583	-$609,942	$1,000	$49,000	$4.84	75
2020 Q2	23,193,481	$119,558,636	+$22,728,554	$270,000	$399,000	$5.18	82
2020 Q1	18,491,349	$80,617,885	+$40,696,600			$4.36	58
2019 Q4	9,173,287	$36,785,829	-$692,673			$4.01	54
2019 Q3	9,424,823	$30,911,164	-$5,403,616			$3.28	53
2019 Q2	10,006,616	$77,130,207	+$6,865,621			$7.71	52
2019 Q1	9,915,066	$175,891,040	+$12,159,109			$17.74	50
2018 Q4	9,330,849	$220,207,047	+$13,725,399			$23.6	39
2018 Q3	8,803,977	$188,496,000	+$21,744,048			$21.41	35
2018 Q2	7,912,306	$135,154,730	+$104,953,779			$17.3	26